ReviewHealthcare (Basel, Switzerland)2024

Harnessing the Synergy of SGLT2 Inhibitors and Continuous Ketone Monitoring (CKM) in Managing Heart Failure among Patients with Type 1 Diabetes.

Nicola Tecce et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.